CoChat

Antidepressant-Like Effect of Sodium Butyrate is Associated with an Increase in TET1 and in 5-Hydroxymethylation Levels in the Bdnf Gene

Open access
Wei, Y. B., Melas, P. A., Wegener, G., Mathe, A. A., Lavebratt, C. · 2015 · International Journal of Neuropsychopharmacology

The DOI matches its Crossref record; 78 of the 78 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Epigenetic drugs like sodium butyrate (NaB) show antidepressant-like effects in preclinical studies, but the exact molecular mechanisms of the antidepressant effects remain unknown. While research using NaB has mainly focused on its role as a histone deacetylase inhibitor (HDACi), there is also evidence that NaB affects DNA methylation. METHODS: The purpose of this study was to examine NaB's putative antidepressant-like efficacy in relation to DNA methylation changes in the prefrontal cortex of an established genetic rat model of depression (the Flinders Sensitive Line [FSL]) and its controls (the Flinders Resistant Line). RESULTS: The FSL rats had lower levels of ten-eleven translocation methylcytosine dioxygenase 1 (TET1), which catalyzes the conversion of DNA methylation to hydroxymethylation. As indicated by the behavioral despair test, chronic administration of NaB had antidepressant-like effects in the FSL and was accompanied by increased levels of TET1. The TET1 upregulation was also associated with an increase of hydroxymethylation and a decrease of methylation in brain-derived neurotrophic factor (Bdnf), a gene associated with neurogenesis and synaptic plasticity. These epigenetic changes were associated with a corresponding BDNF overexpression. CONCLUSIONS: Our data support the antidepressant efficacy of HDACis and suggest that their epigenetic effects may also include DNA methylation changes that are mediated by demethylation-facilitating enzymes like TET1.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/ijnp/pyu032

Cites

78 of 78 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1. The behavioral despair test (Porsolt forced swimming test) was used in our study to evaluate the antidepressant-like effects of NaB. In line with the use of FSL as a genetic model of depression-like states, Veh-treated FSL animals showed significantly higher immobility compared to the FRL-Veh. Treatment with NaB significantly decreased the immobility time in the FSL but had no effects in the FRL strain. Data are presented as means ± SEM. n = 7 animals per group. **p < 0.01.
Figure 1. The behavioral despair test (Porsolt forced swimming test) was used in our study to evaluate the antidepressant-like effects of NaB. In line with the use of FSL as a genetic model of depression-like states, Veh-treated FSL animals showed significantly higher immobility compared to the FRL-Veh. Treatment with NaB significantly decreased the immobility time in the FSL but had no effects in the FRL strain. Data are presented as means ± SEM. n = 7 animals per group. **p < 0.01.CC BY-NC · PubMed Central
Figure 2. Gene expression levels of Tet and Dnmt mRNAs were measured in the prefrontal cortex of Veh- and NaB-treated FSL and FRL animals using qRT-PCR. Differences found on the mRNA levels were also tested on the protein levels using the Western blot. (A) Only Tet1 mRNA was differentially expressed between FRL-Veh and FSL-Veh, with reduced levels in the FSL. NaB treatment significantly increased Tet1 mRNA expression in the FSL-NaB group. (B) TET1 protein levels were also reduced in FSL-Veh and were “rescued” in the FSL-NaB animals. (C) Even though Dnmt1 mRNA levels were reduced in the FSL-NaB group, (D) protein measurements of DNMT1 did not reach a statistically significant level of difference. Gene expression data are presented as relative quantifications (R.Q.); two reference genes (Gapdh and Ppia) were used for normalization. Protein data are presented as % of FRL-Veh. Lower panels in (B) and (D) show representative Western blot images of TET1 and DNMT1 from the same gel, respectively, with β-actin as loading control. For each panel (B) and (D), the Western blot images were from the same gel. Data are presented as group means ± SEM. For all figures: n = 5–7 animals per group; n = 1 FSL-Veh outlier excluded. (A) n = 1 FSL-NaB outlier excluded. *p < 0.05, **p < 0.01, ***p < 0.001.
Figure 2. Gene expression levels of Tet and Dnmt mRNAs were measured in the prefrontal cortex of Veh- and NaB-treated FSL and FRL animals using qRT-PCR. Differences found on the mRNA levels were also tested on the protein levels using the Western blot. (A) Only Tet1 mRNA was differentially expressed between FRL-Veh and FSL-Veh, with reduced levels in the FSL. NaB treatment significantly increased Tet1 mRNA expression in the FSL-NaB group. (B) TET1 protein levels were also reduced in FSL-Veh and were “rescued” in the FSL-NaB animals. (C) Even though Dnmt1 mRNA levels were reduced in the FSL-NaB group, (D) protein measurements of DNMT1 did not reach a statistically significant level of difference. Gene expression data are presented as relative quantifications (R.Q.); two reference genes (Gapdh and Ppia) were used for normalization. Protein data are presented as % of FRL-Veh. Lower panels in (B) and (D) show representative Western blot images of TET1 and DNMT1 from the same gel, respectively, with β-actin as loading control. For each panel (B) and (D), the Western blot images were from the same gel. Data are presented as group means ± SEM. For all figures: n = 5–7 animals per group; n = 1 FSL-Veh outlier excluded. (A) n = 1 FSL-NaB outlier excluded. *p < 0.05, **p < 0.01, ***p < 0.001.CC BY-NC · PubMed Central
Figure 3. DNA hydroxymethylation (5hmC) and methylation (5mC) analyses were performed in the prefrontal cortex of Veh- and NaB-treated FRL and FSL animals. (A) Global 5hmC level was measured using ELISA and showed no significant changes between any of the groups. Data are presented as the average percent of the genomic DNA cytosines that are hydroxymethylated at the 5th carbon. (B) Region-specific 5hmC and 5mC levels were measured at the Bdnf promoter 4 (P4) region, spanning the transcription start site, and data are presented as relative values. FSL-Veh animals had a significant reduction in 5hmC levels at the Bdnf P4 region, and NaB treatment was associated with increased 5hmC levels in the FSL-NaB group. In contrast, 5mC levels at the same locus showed an inverse pattern compared to 5hmC levels, with hypermethylation in FSL-Veh but hypomethylation in the FSL-NaB group. (C) Pearson’s correlation analysis supported an inverse relationship between 5hmC and 5mC level at the Bdnf P4 locus (rho = -0.48; p = 0.045). Data in A and B are presented as group means ± SEM. n = 4–6 animals per group; n = 1 FSL-Veh outlier excluded. *p < 0.05, **p < 0.01.
Figure 3. DNA hydroxymethylation (5hmC) and methylation (5mC) analyses were performed in the prefrontal cortex of Veh- and NaB-treated FRL and FSL animals. (A) Global 5hmC level was measured using ELISA and showed no significant changes between any of the groups. Data are presented as the average percent of the genomic DNA cytosines that are hydroxymethylated at the 5th carbon. (B) Region-specific 5hmC and 5mC levels were measured at the Bdnf promoter 4 (P4) region, spanning the transcription start site, and data are presented as relative values. FSL-Veh animals had a significant reduction in 5hmC levels at the Bdnf P4 region, and NaB treatment was associated with increased 5hmC levels in the FSL-NaB group. In contrast, 5mC levels at the same locus showed an inverse pattern compared to 5hmC levels, with hypermethylation in FSL-Veh but hypomethylation in the FSL-NaB group. (C) Pearson’s correlation analysis supported an inverse relationship between 5hmC and 5mC level at the Bdnf P4 locus (rho = -0.48; p = 0.045). Data in A and B are presented as group means ± SEM. n = 4–6 animals per group; n = 1 FSL-Veh outlier excluded. *p < 0.05, **p < 0.01.CC BY-NC · PubMed Central
Figure 4. The expression of Bdnf P4 and total Bdnf mRNA levels were measured in the prefrontal cortex of Veh- and NaB-treated FRL and FSL animals using qRT-PCR; BDNF protein levels were tested using the Western blot. (A) While Bdnf P4 was downregulated in the FSL-Veh, NaB treatment increased Bdnf P4 levels in the FSL-NaB group. (B) This expression pattern was similar to the 5hmC level pattern at the Bdnf P4 locus. Total Bdnf exhibited a similar expression pattern as the Bdnf P4–driven expression. BDNF protein levels were also reduced in FSL-Veh and were “rescued” in the FSL-NaB animals. Gene expression data are presented as relative quantifications (R.Q.); two reference genes (Gapdh and Ppia) were used for normalization. Protein data are presented as % of FRL-Veh. The lower panel in (B) shows representative Western blot images of BDNF from the same gel with β-actin as loading control. All data represent group means ± SEM. n = 5–7 animals per group; n = 1 FRL-NaB outlier excluded in mRNA analysis. *p < 0.05, **p < 0.01.
Figure 4. The expression of Bdnf P4 and total Bdnf mRNA levels were measured in the prefrontal cortex of Veh- and NaB-treated FRL and FSL animals using qRT-PCR; BDNF protein levels were tested using the Western blot. (A) While Bdnf P4 was downregulated in the FSL-Veh, NaB treatment increased Bdnf P4 levels in the FSL-NaB group. (B) This expression pattern was similar to the 5hmC level pattern at the Bdnf P4 locus. Total Bdnf exhibited a similar expression pattern as the Bdnf P4–driven expression. BDNF protein levels were also reduced in FSL-Veh and were “rescued” in the FSL-NaB animals. Gene expression data are presented as relative quantifications (R.Q.); two reference genes (Gapdh and Ppia) were used for normalization. Protein data are presented as % of FRL-Veh. The lower panel in (B) shows representative Western blot images of BDNF from the same gel with β-actin as loading control. All data represent group means ± SEM. n = 5–7 animals per group; n = 1 FRL-NaB outlier excluded in mRNA analysis. *p < 0.05, **p < 0.01.CC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 9

  1. Biard, 1992, Cancer Research, 52, 5213
  2. 2012, EOMD, 17, 105
  3. de Haan, 1986, Cancer Research, 46, 713
  4. 2012, Science Translational Medicine, 4, 155
  5. 2011, 5, S12
  6. 2011, Science Translational Medicine, 3, 107
  7. Porsolt, 1977, Archives internationales de pharmacodynamie et de th rapie, 229, 327
  8. SARKAR, 2011, Anticancer Research, 31, 2723
  9. 2013, 7, 55

Cited by

See all 194

Metadata

Authors
Wei, Y. B., Melas, P. A., Wegener, G., Mathe, A. A., & Lavebratt, C.
Affiliations
Aarhus University (DK)
Corresponding author
Wei, Y. B.
Venue
International Journal of Neuropsychopharmacology
Published
2014-10-31
Volume
18
Issue
2
Pages
pyu032-pyu032
ISSN
  • 1461-1457 (ISSN-L)
  • 1469-5111
OpenAlex
W2128870654
Cited by
186
References
78
Citations by year
2026: 8 · 2025: 26 · 2024: 21 · 2023: 22 · 2022: 20 · 2021: 17 · 2020: 21 · 2019: 16 · 2018: 10 · 2017: 9 · 2016: 11 · 2015: 5
FWCI
6.05
Type
journal article
Language
en
Open access
Licence
cc-by-nc
Locations
  • The International Journal of Neuropsychopharmacology (publishedVersion, cc-by-nc)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • HighWire Press Open Archive (submittedVersion)
  • Boloka Institutional Repository (North-west University) (submittedVersion)
Funders
  • Sundhed og Sygdom, Det Frie Forskningsråd
  • Fredrik och Ingrid Thurings Stiftelse
  • Lundbeckfonden
  • Karolinska Institutet
  • Stockholms Läns Landsting
  • Vetenskapsrådet (2010-03631, 2010-3631 CL, 10414)
  • H. Lundbeck A/S
  • Medical Research Council
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
Keywords
sodium butyrate, antidepressant-like effects, TET1, 5-hydroxymethylation, DNA methylation, brain-derived neurotrophic factor, histone deacetylase inhibitors, epigenetic drugs, depression, Flinders Sensitive Line, prefrontal cortex, demethylation, neurogenesis, synaptic plasticity
MeSH terms
Animals, Antidepressive Agents, Depressive Disorder, Disease Models, Animal, Male, Up-Regulation, Prefrontal Cortex, DNA Methylation, Brain-Derived Neurotrophic Factor, Butyric Acid, Dioxygenases, Rats, Histone Deacetylase Inhibitors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.